TRML Tourmaline Corp Year-over-year net earnings per share growth for the last 12 months
Current quarterly EPS dynamics demonstrate the strategy of Tourmaline Bio, Inc. (TRML) to position itself for acquisition by pharma behemoths. The indicator stands at -31.70. Growth is driven by trials of the TOUR006 antibody targeting cardiovascular pathologies. Business efficiency is supported by an asset-light model, where drug production is fully outsourced to third-party contractors to ensure supply stability.
Tourmaline - analytical breakdowns and key metrics (TRML)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Equity Ratio Tourmaline Bio, Inc.|TRML - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Tourmaline Bio, Inc.|TRML - Company Cumulative Debt|Debt to Book Value Tourmaline Corp|TRML - Company Long-Term Debts|Company Short-Term Debt Tourmaline Bio|Quick Liquidity tourmalinebio.com
- earnings and market multiples details:
TRML - Net Income|Projected Future Earnings Tourmaline Bio, Inc.|TRML - P/E Multiple|Future Price to Earnings Tourmaline Corp|TRML - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Tourmaline Corp|TRML - Operating income before deduction of amortization|Earnings per share for the last twelve months Tourmaline Bio|TRML - Earnings per share for the last 12 months|Quarterly EPS earnings growth tourmalinebio.com|TRML - Earnings per share growth rate in current year|Expected earnings per share growth for next year Tourmaline Bio, Inc.
Comprehensive company analysis:Tourmaline Bio, TRML
For Tourmaline Bio, Inc. (TRML), the efficiency of outsourcing clinical trials is directly reflected in net income dynamics. This metric calculates the percentage change in EPS per quarter, neutralizing time gaps between reports. By analyzing the quarterly earnings per share growth rate, an investor assesses management's ability to control vendor costs. An increase in this indicator confirms the scalability of the virtual business model. A steady rise in profit growth rates reduces the risk of capital drawdowns.
Competitor analysis
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|ADPT: Year-over-year net earnings per share growth for the last 12 months|Celldex Corp - Year-over-year earnings per share growth rate for the last twelve months|Aurinia Pharmaceuticals (AUPH) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months biocryst.com (BCRX)|Year-over-year net earnings per share growth for the last 12 months VERA|Quarterly EPS earnings growth Dianthus Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months Pharvaris Corp (PHVS)|ABCL (AbCellera Bio) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Precigen, Inc. PGEN|PHAR - Year-over-year net earnings per share growth for the last 12 months|Nektar Therapeutics Inc. - Quarterly EPS earnings growth|UPB - Quarterly EPS earnings growth|Zenas Biopharma, Inc. (ZBIO) - Year-over-year earnings per share growth for the last twelve months|IMNM (Immunome Bio) - Year-over-year earnings per share growth for the last twelve months|GOSS (Gossamer Bio, Inc.) - Quarterly EPS earnings growth|kalvista.com (KALV) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Septerna (SEPN)|Pieris Pharma - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth SVRA (Savara Corp)|Rigel Corp (RIGL) - Earnings per share growth in annualized terms for the last twelve months|ANAB: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ATXS (astriatx.com)|ENGN: Quarterly EPS earnings growth|RAPT (rapt.com) - Year-over-year earnings per share growth for the last twelve months|JBIO (Aerovate Therapeutics, Inc.) - Quarterly EPS earnings growth|Aclaris Therapeutics, Inc (ACRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Kyverna Therapeutics (KYTX)|TLSA - Earnings per share growth in annualized terms for the last twelve months|Cabaletta Bio - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months VTYX|Theratechnologies Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Avalo Therapeutics Inc AVTX|Eledon Pharmaceuticals (ELDN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AGEN|CLYM (Climb Bio) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months zurabio.com (ZURA)|Year-over-year net earnings per share growth for the last 12 months ATYR (aTyr)|Year-over-year net earnings per share change for the last twelve months adagene.com|Ikena Oncology - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months STTK (Shattuck Labs Inc)|EQ - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months CNTB (Connect Biopharma)|immunic-therapeutics.com (IMUX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Atara Bio|Year-over-year earnings per share growth for the last twelve months InflaRx NV|Year-over-year earnings per share growth for the last twelve months XFOR|Year-over-year earnings per share growth for the last twelve months Adicet Bio (ACET)|CELU: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth INMB (INmune Bio Corp)|Year-over-year earnings per one share growth for the last 12 months BRNS|Kezar Life Sciences - Quarterly EPS earnings growth|SABS - Quarterly EPS earnings growth|Akari Therapeutics Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Enlivex Therapeutics Ltd. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Q32 Bio Inc|Year-over-year net earnings per share growth for the last 12 months GeoVax Corp (GOVX)|Quarterly EPS earnings growth EDSA|Quarterly EPS earnings growth ibioinc.com (IBIO)|Carisma Therapeutics Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months XTLB|Bolt Bio - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months HCW Biologics Inc. HCWB|aptevotherapeutics.com (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months aimimmuno.com|Year-over-year earnings per share growth for the last twelve months Aditxt Inc.|Year-over-year net earnings per share growth for the last 12 months GRI Bio Inc (GRI)|Year-over-year net earnings per share growth for the last 12 months XRTX (XORTX)|Quarterly EPS earnings growth Vyome Therapeutics (HIND)|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences REVB|INDP: Year-over-year earnings per share growth for the last 12 months|Scinai Immunotherapeutics Ltd. - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months CalciMedica, Inc.|AFMD (affimed.com) - Year-over-year net earnings per share growth for the last 12 months|ALLK: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|Earnings per share growth in annualized terms for the last twelve months IGM Bio IGMS|Year-over-year net earnings per share growth for the last 12 months ITOS (iTeos Therapeutics, Inc.)|Quarterly EPS earnings growth Ocean Biomedical Inc (OCEA)|Year-over-year earnings per share growth for the last twelve months TC BioPharm (Holdings) PLC TCBP|Year-over-year earnings per one share growth for the last 12 months THRD
